In the present study, we observed that BACH1 expression was higher in the hepatocytes of individuals with obesity than those of lean individuals and in the livers of patients with NAFLD and diabetic mice than in normal control livers. This evidence concerns the gene BACH1 and metabolic dysfunction-associated steatotic liver disease.